Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy

Current cancer therapies have encountered adverse response due to poor therapeutic efficiency, severe side effects and acquired resistance to multiple drugs. Thus, there are urgent needs for finding new cancer-targeted pharmacological strategies. In this review, we summarized the current understandi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bin-Bin, Wang, Bo, Zhu, Cheng-Ming, Tang, Di, Pang, Jun, Zhao, Jing, Sun, Chun-Hui, Qiu, Miao-Juan, Qian, Zhi-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926117/
https://www.ncbi.nlm.nih.gov/pubmed/31891127
http://dx.doi.org/10.1016/j.cdtm.2019.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926117/
https://www.ncbi.nlm.nih.gov/pubmed/31891127
http://dx.doi.org/10.1016/j.cdtm.2019.08.006

Ejemplares similares